Aleafia Health Announces In-Kind Payment of Interest on Secured Convertible Debentures
Aleafia Health Announces In-Kind Payment of Interest on Secured Convertible Debentures
TORONTO, June 22, 2023 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSX: AH, OTCQB: ALEAF) ("Aleafia Health" or the "Company") announces that it is electing to pay interest in-kind on its (a) 8.50% Series A Secured Debentures Due June 30, 2024 (the "Series A Debentures"), (b) 8.50% Series B Secured Debentures Due June 30, 2026 (the "Series B Debentures"), and (c) 8.50% Series C Secured Convertible Debentures Due June 30, 2028 (the "Series C Debentures" and, collectively with the Series A Debentures and the Series B Debentures, the "Debentures").
多倫多，2023年6月22日(環球社)--Aleafia Health Inc.(多倫多證券交易所股票代碼：AH，OTCQB：ALEAF)(“Aleafia Health“或”公司)宣佈選擇支付其(A)8.50%於2024年6月30日到期的A系列擔保債券的實物利息(首輪債券)，(B)8.50%2026年6月30日到期的B系列擔保債券(“B系列債券)，及(C)8.50%於2028年6月30日到期的C系列有擔保可轉換債券(“C系列債券連同A系列債券和B系列債券，債券“)。
On June 30, 2023, holders of Debentures as of June 19, 2023 (the "Record Date") will be issued additional Debentures in payment of accrued interest equal to $42.50 per every $1,000 in Debentures held as of the Record Date. As the Record Date has passed, trading in the Debentures will be halted by the Toronto Stock Exchange at the opening on Thursday, June 22, 2023 and will resume trading at the opening on Friday, June 23, 2023 on an ex-distribution basis.
2023年6月30日，截至2023年6月19日的債券持有人(“記錄日期“)將額外發行債券，以支付截至記錄日期每1,000美元債券的應計利息42.50美元。由於創紀錄日期已過，債券將於2023年6月22日(星期四)開盤時由多倫多證券交易所暫停交易，並將於2023年6月23日(星期五)開盤時恢復交易。
For Investor & Media Relations
投資者與媒體關係
Matthew Sale, CFO
1-833-879-2533
IR@Aleafiahealth.com
LEARN MORE:
首席財務官馬修·賽爾
1-833-879-2533
郵箱：IR@AleafiaHealth.com
瞭解詳細資訊：
About Aleafia Health:
關於Aleafia Health：
The Company is a federally licensed Canadian cannabis company offering cannabis products in Canadian adult-use and medical markets and in select international markets, including Australia and Germany. The Company operates a virtual medical cannabis clinic staffed by physicians and nurse practitioners which provide health and wellness services across Canada.
該公司是一家獲得聯盟許可的加拿大大麻公司，在加拿大成人使用和醫療市場以及包括澳大利亞和德國在內的特定國際市場提供大麻產品。該公司經營著一個虛擬醫用大麻診所，由醫生和護士從業人員組成，在加拿大各地提供健康和保健服務。
The Company owns three licensed cannabis production facilities and operates a strategically located distribution centre all in the province of Ontario, including the largest, outdoor cannabis cultivation facility in Canada. The Company produces a diverse portfolio of cannabis and cannabis derivative products including dried flower, pre-roll, milled, vapes, oils, capsules, edibles, sublingual strips and topicals.
該公司擁有三個獲得許可的大麻生產設施，並在安大略省經營一個位於戰略位置的配送中心，包括加拿大最大的戶外大麻種植設施。該公司生產各種大麻和大麻衍生產品組合，包括乾花、預捲、碾磨、蒸氣、油、膠囊、可食用產品、舌下帶和外用藥片。
譯文內容由第三人軟體翻譯。